Advisors cite rising volatility, inflation, and geopolitical risks as top concerns for Q2 2026 Traditional 60/40 portfolios under pressure amid simultaneous stock and bond weakness Energy, supply ...

Every time Madison publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

Cambridge, MA (March 23, 2026) — A team of astronomers led by the Center for Astrophysics | Harvard and Smithsonian have for the first time used galactic archaeology, the study of detailed chemical ...

Long before the glam, the colorful wigs and ever-changing beauty looks, the fame and arena tours, Cardi B had a complicated relationship with her hair. “So I’m not even gonna lie, when I was younger, ...

SAN FRANCISCO, March 13 (Reuters) - When Jensen Huang strides onto the stage of a packed hockey arena to kick off Nvidia's (NVDA.O), opens new tab annual developer conference on Monday, he is likely ...

It’s safe to say that the 29-year-old has established himself as the number one option for Boston this season. People tend to forget that Brown brought home the Finals MVP award in 2024. There’s no ...

Jaylen Brown opens up about his relationship with Jayson Tatum. He also added that both of them are on the same page, and that’s bringing another title for the Boston Celtics. Before Jayson Tatum ...

Miniature organs grown in the lab can organize themselves into complex shapes. But they never do it the same way twice, which makes it hard to use these so-called "organoids" to study disease. Now, ...

Over the next decade, the global market for decision-making AI agents could multiply by a factor of more than 25 to a value of $215 billion. C3.ai is a player in that market, but its sales are slowing ...

Anyone who's ever grown an indeterminate tomato plant or sprawling squash vine in their garden knows that many edibles need a strong support system to maximize your harvest. But as easy as it is to ...

After UCB’s Bimzelx scored five approvals in just two years, the Belgian drugmaker has quickly made a blockbuster out of its up-and-coming immunology powerhouse. As the first med to selectively ...